Buradasınız

Anasayfa » Content

Sistemik Lupus Eritematozusda Böbrek Biyopsisinde Nadir Görülen Bir Lezyon; IgA Nefropatisi: Olgu Sunumu ve Literatürün Gözden Geçirilmesi

IgA Nephropathy: A Rare Lesion in Renal Biopsy in Systemic Lupus Erythematosus: Case Reports and Review of Literature

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 2013
DOI: 
10.5262/tndt.2013.1003.11

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
Lupus nephritis is an infl ammation of the kidney caused by systemic lupus erythematosus (SLE). Lupus nephritis is a frequent complication of SLE that increases mortality and morbidity. Minimal glomerular lesions, mesangial proliferative, focal proliferative, membranous and diffuse glomerulonephritis can be seen in renal biopsies of patients with lupus nephritis. It has been reported that non-lupus nephritis can also rarely occur in SLE. While non-lupus nephritis cases usually manifest as focal segmental glomerulosclerosis, they have been seen rarely as IgA nephropathy. In this paper, we have represented a SLE case with IgA nephropathy on renal biopsy.
Bookmark/Search this post with
Abstract (Original Language): 
Sistemik lupus eritematozusta (SLE) morbidite ve mortaliteyi arttıran lupus nefritine (LN) sık olarak rastlanır. Lupus nefritinde böbrek biyopsisinde; minimal glomerüler lezyonlar, mezengioproliferatif, fokal proliferatif, membranöz ve diffüz proliferatif glomerülonefrit görülebilmektedir. Ancak SLE’de nadiren non-lupus nefritler de bildirilmiştir. Non-lupus nefritlerde en sık fokal segmental glomerüloskleroz görülmekle birlikte nadiren IgA nefropatiside (IgANP) bildirilmiştir. Bu yazıda böbrek biyopsisinde IgANP saptanan bir SLE olgusu sunulmuştur.
FULL TEXT (PDF): 
PDF icon arastirmax-sistemik-lupus-eritematozusda-bobrek-biyopsisinde-nadir-gorulen-bir-lezyon-iga-nefropatisi-olgu-sunumu-literaturun-gozden-gecirilmesi.pdf
  • 3
300
303
  • Turkish

REFERENCES

References: 

1. Hamuryudan V: Lupus Nephritis. Rheumatology Research and
Education Society Bulletin 1997; 1: 71
2. Sezer T, Yakupoğlu G: Lupus Nephritis. Turk Neph Dial Transpl
1995; 3:137-140
3. Feehally J, Johnson K: Comprehensive Clinical Nephrology, (2nd
ed). London: Harcourt, 2003; Section 5 Chapters 26 and 27
4. Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN,
Truong LD: Non-lupus nephritides in patients with systemic lupus
ertyhematosus: A comprehensive clinicopathologic study and
review of the literature. Hum Pathol 2001; 32(10): 1125-1135
5. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov
S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn
JA, D’Agati V, D’Amico G, Emancipator S, Emma F, Ferrario F,
Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas
M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K,
Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH,
Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang
H, Weening JJ, Yoshikawa N, Zhang H: The Oxford classifi cation of
IgA nephropathy: Rationale, clinicopathological correlations, and
classifi cation. Kidney Int 2009; 76: 534-545
6. Rus V, Maury EE, Hochberg MC: Epidemiology of Systemic Lupus
Erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois’ Lupus
Erythematosus. (7th ed). Philadelphia, PA: Lippincott Williams &
Wilkins, 2007; 34-44
7. Inman RD, Day NK: Immunologic and clinical aspects of immune
complex disease. Am J Med 1981; 70: 1097-106
8. Yung S, Chan TM: Anti-DNA antibodies in the pathogenesis of
lupus nephritis the emerging mechanisms. Autoimmun Rev Feb
2008; 7(4): 317-321
9. D’Agati VD, Appel GB: Lupus Nephritis: Pathology and
Pathogenesis. In: Wallace DJ, Hahn BH,eds. Dubois’ Lupus
Erythematosus. (7th ed). Philadelphia, PA: Lippincott Williams &
Wilkins, 2007; 1094-11110. Grande JP: Mechanisms of progression of renal damage in lupus
nephritis: Pathogenesis of renal scarring. Lupus 1998; 7(9): 604-
610
11. Rahman A, Isenberg DA: Systemic lupus erythematosus. N Engl J
Med 2008; 358(9): 929-939
12. Berger J, Hinglais N: Les dépots intercapillaries d’IgA-IgG. J Urol
Nephrol (Paris) 1968; 74:694-700.
13. Tomino Y: IgA nephropathy today. Contrib Nephrol 2007; 157:
1-255
14. D’Amico G: The commonest glomerulonephritis in the world: IgA
nephropathy. Quart J Med 1987; 245: 709-727
15. Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri
G, D’Amico G: Fractional urinary excretion of IgG is the most
powerful predictor of renoprotection by ACE inhibitors in IgA
nephropathy. J Nephrol 2009; 22(3): 387-396
16. Abuelo JG, Espara AR. Mataresc RA, Endren KG, Carvalho JS,
Allegra SR: Crescentic IgA Nephropathy. Medicine 1984; 63: 396-
406
17. Stilmant MM, Bolton WK, Sturgill BC, Schmttt GW, Couser
WG: Crescentic glomerulonephritis without immune deposits:
Clinicopathologic features. Kidney Hit 1979; 15: 184-195
18. Berthoux FC, Mohey H , Afi ani A: Natural history of primary IgA
nephropathy. Semin Nephrol 2008; 28(1): 4-9
19. Corrado A, Quarta L, Di Palma AM, Gesualdo L, Cantatore FP: IgA
nephropathy in systemic lupus erythematosus. Clin Exp Rheumatol
2007; 25(3): 467-469
20. Churg J, Sobin LH: Renal Disease. Classifi cation and Atlas of
Glomerular Diseases. Tokyo: Igaku-Shoin Medical Publishers,
1981; 127-132
21. Mac-Moune Lai F, Li EK, Tang NL, Li PK, Lui SF, Lai KN: IgA
nephropathy: A rare lesion in systemic lupus erythematosus. Mod
Pathol 1995; 8: 5-10
22. Berger J, Yaneva H, Nabarra B, Barbanel C: Recurrence of
mesangial deposition of IgA after renal transplantation. Kidney Int
1975; 7: 232-241
23. Coplon NS, Diskin CJ, Petersen J, Swenson RS: The long-term
clinical course of systemic lupus erythematosus in end stage renal
disease. N Engl J Med 1983; 308: 186-190
24. Goshen E, Livne A, Nagy J, Sarov I, Shoenfeld Y: Antinuclear
autoantibodies in sera of patients with IgA nephropathy. Nephron
1990; 55: 33-36

Thank you for copying data from http://www.arastirmax.com